Steroid Therapy in Adrenal Insufficiency

Addison’s disease or autoimmune adrenalitis: These are autoimmune conditions, constituting 80% of all cases. Autoimmune adrenalitis may be part of Type 2 autoimmune polyglandular syndrome, which can include type 1 diabetes, hyperthyroidism, and autoimmune thyroid disease (also known as Hashimoto’s thyroiditis), and Hashimoto’s disease. Hypogonadism may also present with this syndrome. Other diseases that are more common in people with autoimmune adrenalitis include premature ovarian failure, celiac disease, and autoimmune gastritis with pernicious anemia. Other subtypes include idiopathic (unknown) cause, congenital adrenal hyperplasia or an adenoma (tumor) of the adrenal gland.

[1]  eep,et al.  Steroid Therapy in Adrenal Insufficiency , 2017 .

[2]  P. Dahlqvist,et al.  Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study , 2017, European journal of endocrinology.

[3]  Stefan R Bornstein,et al.  Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. , 2016, The Journal of clinical endocrinology and metabolism.

[4]  M. Quinkler,et al.  Modified-release hydrocortisone decreases BMI and HbA1c in patients with primary and secondary adrenal insufficiency. , 2015, European journal of endocrinology.

[5]  P. Dahlqvist,et al.  Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency , 2014, European journal of endocrinology.

[6]  M. Goran,et al.  Blunted nocturnal cortisol rise is associated with higher carotid artery intima-media thickness (CIMT) in overweight African American and Latino youth , 2013, Psychoneuroendocrinology.

[7]  A. Grossman,et al.  THERAPY OF ENDOCRINE DISEASE: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe , 2013, European journal of endocrinology.

[8]  M. Debono,et al.  What is the best approach to tailoring hydrocortisone dose to meet patient needs in 2012? , 2013, Clinical endocrinology.

[9]  W. Arlt The approach to the adult with newly diagnosed adrenal insufficiency. , 2009, The Journal of clinical endocrinology and metabolism.

[10]  G. Tucker,et al.  Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia , 2006, Clinical endocrinology.

[11]  A. Rostami-Hodjegan,et al.  Weight‐related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency , 2004, Clinical endocrinology.

[12]  J. Wass,et al.  Oxford Handbook of Endocrinology and Diabetes , 2002 .

[13]  R. Carey The Changing Clinical Spectrum of Adrenal Insufficiency , 1997, Annals of Internal Medicine.